{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:18:28Z","timestamp":1751469508493,"version":"3.40.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 87395"],"award-info":[{"award-number":["MOP 87395"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010450","name":"Ministry of Higher Education and Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010450","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1002\/jps.23348","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T22:02:28Z","timestamp":1352239348000},"page":"262-270","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Rat Serum Lipoproteins on mRNA Levels and Amiodarone Metabolism by Cultured Primary Rat Hepatocytes"],"prefix":"10.1016","volume":"102","author":[{"given":"Dion R.","family":"Brocks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia A.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ben\u2010Eltriki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jigar P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman O.","family":"El\u2010Kadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1002\/jps.23348_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrd2353","article-title":"Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: Implications for drug discovery","volume":"7","author":"Wasan","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/jps.23348_bb0015","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3109\/00498254.2011.654001","article-title":"Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407","volume":"42","author":"Lee","year":"2012","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1002\/jps.23348_bb0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.18433\/J3VG6T","article-title":"Decrease in brain distribution of fluvoxamine in experimental hyperlipidemic rats","volume":"14","author":"Fukushima","year":"2011","journal-title":"J Pharm Pharm Sci"},{"issue":"9","key":"10.1002\/jps.23348_bb0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/00498254.2011.580019","article-title":"Effects of experimental hyperlipidaemia on the pharmacokinetics of docetaxel in rats","volume":"41","author":"Lee","year":"2011","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1002\/jps.23348_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1018896912889","article-title":"Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat","volume":"16","author":"Eliot","year":"1999","journal-title":"Pharm Res"},{"issue":"1","key":"10.1002\/jps.23348_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bdd.476","article-title":"The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat","volume":"27","author":"Brocks","year":"2006","journal-title":"Biopharm Drug Dispos"},{"key":"10.1002\/jps.23348_bb0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/bdd.457","article-title":"Pharmacokinetics of amiodarone in hyperlipidemic and simulated high fat\u2010meal rat models","volume":"26","author":"Shayeganpour","year":"2005","journal-title":"Biopharm Drug Dispos"},{"issue":"8","key":"10.1002\/jps.23348_bb0045","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/jps.10182","article-title":"The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food\u2010effect studies involving drugs that bind to lipoproteins","volume":"91","author":"Brocks","year":"2002","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1002\/jps.23348_bb0050","doi-asserted-by":"crossref","first-page":"E672","DOI":"10.1208\/aapsj080477","article-title":"Insights into the effects of hyperlipoproteinemia on cyclosporine A biodistribution and relationship to renal function","volume":"8","author":"Aliabadi","year":"2006","journal-title":"AAPS J"},{"issue":"6","key":"10.1002\/jps.23348_bb0055","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1476-5381.2010.00983.x","article-title":"Effect of experimental hyperlipidaemia on the electrocardiographic effects of repeated doses of halofantrine in rats","volume":"161","author":"Patel","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1002\/jps.23348_bb0060","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/jps.21607","article-title":"The effect of experimental hyperlipidemia on the stereoselective tissue distribution, lipoprotein association and microsomal metabolism of (+\/\u2212)\u2010halofantrine","volume":"98","author":"Patel","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23348_bb0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijpharm.2008.05.019","article-title":"The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat","volume":"361","author":"Shayeganpour","year":"2008","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/jps.23348_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/00498254.2010.529178","article-title":"The effect of increased lipoprotein levels on the pharmacokinetics of ketoconazole enantiomers in the rat","volume":"41","author":"Hamdy","year":"2011","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1002\/jps.23348_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0b013e31819359d1","article-title":"Experimental hyperlipidemia causes an increase in the electrocardiographic changes associated with amiodarone","volume":"53","author":"Hamdy","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1002\/jps.23348_bb0080","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.2042-7158.2010.01245.x","article-title":"Pharmacokinetics of clomipramine, an antidepressant, in poloxamer 407\u2010induced hyperlipidaemic model rats","volume":"63","author":"Kobuchi","year":"2011","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.23348_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2009.01.008","article-title":"Effect of serum lipids on the pharmacokinetics of atazanavir in hyperlipidemic rats","author":"Fukushima","year":"2009","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1002\/jps.23348_bb0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1023\/A:1015831408425","article-title":"High\u2010fat meals increase the clearance of cyclosporine","volume":"7","author":"Gupta","year":"1990","journal-title":"Pharm Res"},{"issue":"7","key":"10.1002\/jps.23348_bb0095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/j.1552-4604.1990.tb01868.x","article-title":"Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration","volume":"30","author":"Gupta","year":"1990","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"10.1002\/jps.23348_bb0100","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/chir.22054","article-title":"Effect of serum lipoproteins on stereoselective halofantrine metabolism by rat hepatocytes","volume":"24","author":"Patel","year":"2012","journal-title":"Chirality"},{"issue":"9","key":"10.1002\/jps.23348_bb0105","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0090-9556(24)02972-6","article-title":"Differences in the pharmacokinetics of peroxisome proliferator\u2010activated receptor agonists in genetically obese Zucker and Sprague\u2013Dawley rats: Implications of decreased glucuronidation in obese Zucker rats","volume":"32","author":"Kim","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1002\/jps.23348_bb0110","first-page":"192","article-title":"Poloxamer 407\u2010mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats","volume":"46","author":"Wout","year":"1992","journal-title":"J Parenter Sci Technol"},{"issue":"6","key":"10.1002\/jps.23348_bb0115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0006-2952(93)90668-M","article-title":"Mechanism of poloxamer 407\u2010induced hypertriglyceridemia in the rat","volume":"46","author":"Johnston","year":"1993","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1002\/jps.23348_bb0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s11095-006-9186-z","article-title":"The influence of hyperlipoproteinemia on in vitro distribution of amiodarone and desethylamiodarone in human and rat plasma","volume":"24","author":"Shayeganpour","year":"2007","journal-title":"Pharm Res"},{"issue":"6","key":"10.1002\/jps.23348_bb0125","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/sj.bjp.0701232","article-title":"Down\u2010regulation of the hepatic cytochrome P450 by an acute inflammatory reaction: Implication of mediators in human and animal serum and in the liver","volume":"121","author":"El\u2010Kadi","year":"1997","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1002\/jps.23348_bb0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tiv.2007.08.003","article-title":"Modulation of TCDD\u2010mediated induction of cytochrome P450 1A1 by mercury, lead, and copper in human HepG2 cell line","volume":"22","author":"Korashy","year":"2008","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"10.1002\/jps.23348_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.1840110115","article-title":"Amiodarone\u2010 and desethylamiodarone\u2010induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes","volume":"11","author":"Somani","year":"1990","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/jps.23348_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real\u2010time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"3","key":"10.1002\/jps.23348_bb0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/bmc.754","article-title":"A liquid chromatography\u2013mass spectrometry assay method for simultaneous determination of amiodarone and desethylamiodarone in rat specimens","volume":"21","author":"Shayeganpour","year":"2007","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"10.1002\/jps.23348_bb0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0887-2333(02)00118-2","article-title":"Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: Effect of L\u2010NAME","volume":"17","author":"Binda","year":"2003","journal-title":"Toxicol In Vitro"},{"issue":"1\u20132","key":"10.1002\/jps.23348_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03190374","article-title":"Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers","volume":"26","author":"Ubeaud","year":"2001","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"10.1002\/jps.23348_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/dmd.32.1.20","article-title":"Suppression of drug\u2010metabolizing enzymes and efflux transporters in the intestine of endotoxin\u2010treated rats","volume":"32","author":"Kalitsky\u2010Szirtes","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1002\/jps.23348_bb0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bbamem.2009.03.003","article-title":"Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells","volume":"1788","author":"Seki","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1002\/jps.23348_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.18433\/J3SG66","article-title":"The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole","volume":"11","author":"Elsherbiny","year":"2008","journal-title":"J Pharm Pharm Sci"},{"issue":"6","key":"10.1002\/jps.23348_bb0175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.euroneuro.2011.10.004","article-title":"Effects of poloxamer 407\u2010induced hyperlipidemia on the pharmacokinetics of carbamazepine and its 10,11\u2010epoxide metabolite in rats: Impact of decreased expression of both CYP3A1\/2 and microsomal epoxide hydrolase","volume":"22","author":"Lee","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"10.1002\/jps.23348_bb0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bdd.599","article-title":"Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone","volume":"29","author":"Shayeganpour","year":"2007","journal-title":"Biopharm Drug Dispos"},{"issue":"2\u20133","key":"10.1002\/jps.23348_bb0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.toxlet.2010.03.019","article-title":"The effect of beta\u2010naphthoflavone on the metabolism of amiodarone by hepatic and extra\u2010hepatic microsomes","volume":"195","author":"Elsherbiny","year":"2010","journal-title":"Toxicol Lett"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915312697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915312697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T09:59:51Z","timestamp":1745143191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915312697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0022354915312697"],"URL":"https:\/\/doi.org\/10.1002\/jps.23348","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}